|
市場調査レポート
商品コード
1375140
南米の神経毒市場の2028年までの予測- 地域別分析- 製品タイプ、用途、エンドユーザー別South America Neurotoxins Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type, Application, and End User |
||||||
|
|
|||||||
|
|||||||
| 南米の神経毒市場の2028年までの予測- 地域別分析- 製品タイプ、用途、エンドユーザー別 |
|
出版日: 2023年08月24日
発行: The Insight Partners
ページ情報: 英文 93 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
南米の神経毒市場は、2023年の2億8,048万米ドルから2028年には5億2,557万米ドルに成長すると予測されています。2023年から2028年までのCAGRは13.4%と推定されます。
革新的なフェイシャルエステ製品の登場が南米神経毒市場を活性化
神経毒の市場全体は、予測期間中、顔面美容の需要増に対応するため、指数関数的に推進すると予想されます。2022年3月、Aquavit Pharmaceuticals, Inc.は、中等度から重度のほうれい線治療を目的としたA型ボツリヌス毒素「DTX-021」の治験新薬（IND）申請を発表しました。この製品は、クロストリジウム・ボツリヌス菌が産生する神経毒に由来する900kDaのタンパク質複合体を高純度に精製し、臨床試験済みの注射用神経調節剤です。また、アクアビットはDTX-022を導入することで臨床試験を加速させており、その最終承認は、神経毒の世界初の汎顔面微量注射として認知されることになります。同様に、減量傾向が続く中、胃ボトックスは非侵襲的な処置を求める患者の間で人気の選択肢となっています。これは、内視鏡技術を用いて特定の胃の部位にボトックスを注入するものです。この技術により、胃の筋肉の収縮が制限されます。この制限により、胃の排出プロセスに時間がかかるため、患者は満腹感を長時間感じることができ、その結果、食欲が減退し、高血圧や糖尿病などの体重関連の健康問題や生活習慣病が改善されます。したがって、革新的な顔面美容製品の出現は、南米の神経毒市場の成長に貢献しています。
南米の神経毒市場の概要
南米の神経毒市場は、ブラジル、アルゼンチン、ベネズエラ、その他南米に区分されます。この市場の成長は主に、低侵襲性および非侵襲性の美容処置の採用の増加、高齢者の間での採用の増加、美容処置に関する一般市民の意識の高まり、技術的に高度でユーザーフレンドリーな製品の入手可能性、美容処置に対する需要の増加によってもたらされます。この地域市場は、ブラジルの経済に直接的な影響を与えた最近の技術開発により、予測期間中に拡大する可能性が高いです。ブラジルでは、ボツリヌス毒素ベースの治療など、幅広い適応症を持つ低侵襲・非侵襲の美容施術の採用が主要な市場促進要因となっています。ブラジルで入手可能なボツリヌス毒素A製剤のブランド名には、ボトックス、ゼオミン、ディスポート、ボトリフト、プロシグネなどがあります。さらに、国際美容形成外科学会（ISAPS）2018年報告書によると、ボツリヌス毒素に基づく治療はブラジルで実施された最も一般的な非外科手術であり、非外科手術全体の51％（約392,530件）を占めました。コスト削減の利点と作業効率の向上が、製造企業が南米に拠点を設ける主な魅力として挙げられています。
南米の神経毒市場の収益と2028年までの予測（金額）
南米の神経毒市場のセグメンテーション
南米の神経毒市場は、製品タイプ、用途、エンドユーザー、国に区分されます。
製品タイプに基づき、南米の神経毒市場はボトックス、ディスポート、ゼノミン、その他に細分化されます。ボトックスセグメントは2023年に最大の市場シェアを記録しました。
用途別では、南米の神経毒市場は治療用と美容用に区分されます。2023年には美容セグメントがより大きな市場シェアを占めました。
エンドユーザー別では、南米の神経毒市場は病院、専門クリニック、皮膚科クリニック、その他に区分されます。病院セグメントが2023年に最大の市場シェアを占めました。
国別では、南米の神経毒市場はブラジル、アルゼンチン、ベネズエラ、その他南米に区分されます。2023年の市場シェアはブラジルが圧倒的でした。
AbbVie Inc、Hugel Inc、Ipsen SA、Medytox Inc、Merz Pharma GmbH &Co KGaAなどが南米神経毒市場で事業を展開する大手企業です。
目次
第1章 イントロダクション
第2章 南米神経毒市場-要点
第3章 調査手法
- 調査範囲
- 2次調査
- 1次調査
第4章 南米神経毒市場- 市場情勢
- 概観
- 南米のPEST分析
- 専門家の見解
第5章 南米の神経毒市場-主要市場力学
- 市場促進要因
- 外見改善のための美容施術の急増
- 革新的な顔面美容製品の出現
- 市場抑制要因
- 不適切/不適当な注射技術
- 今後の動向
- 生殖補助医療（ART）のBOTA
- 影響分析
第6章 南米神経毒市場
- 南米神経毒市場の収益と予測分析
第7章 南米神経毒市場：2028年までの収益と予測：タイプ別
- 南米の神経毒市場のタイプ別収益シェア（2022年、2028年）
- ボトックス
- ディスポート
- ゼオミン
- その他
第8章 南米神経毒市場：用途別収益と2028年までの予測
- 南米の神経毒市場の用途別収益シェア（2022年および2028年）
- 治療用
- 治療用
第9章 南米神経毒市場- エンドユーザー別収益と2028年予測
- 南米の神経毒市場のエンドユーザー別収益シェア（2022年および2028年）
- 病院
- 医療スパおよび美容センター
- 皮膚科クリニック
- その他
第10章 南米の神経毒市場-収益と2028年までの予測-：国別分析
- 南米
- ブラジル
- アルゼンチン
- ベネズエラ
- その他南米
第11章 南米の神経毒市場-業界情勢
- 有機的成長戦略
- 無機的成長戦略
第12章 企業プロファイル
- Merz Pharma GmbH & Co KGaA
- AbbVie Inc
- Ipsen SA
- Medytox Inc
- Hugel Inc
第13章 付録
List Of Tables
- Table 1. South America Neurotoxins Market - Revenue and Forecast to 2028 (US$ Million)
- Table 2. Brazil Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
- Table 3. Brazil Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 4. Brazil Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 5. Argentina: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
- Table 6. Argentina: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 7. Argentina: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 8. Venezuela: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
- Table 9. Venezuela: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 10. Venezuela: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 11. Rest of South America: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
- Table 12. Rest of South America: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 13. Rest of South America: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 14. Recent Organic Growth Strategies in Neurotoxins Market
- Table 15. Recent Inorganic Growth Strategies in the Neurotoxins Market
- Table 16. Glossary of Terms
List Of Figures
- Figure 1. South America Neurotoxin Market Segmentation
- Figure 2. South America Neurotoxin Market by Country
- Figure 3. South America Neurotoxin Market Overview
- Figure 4. South America Neurotoxin Market, By Type
- Figure 5. South America Neurotoxin Market, By Country
- Figure 6. South America: PEST Analysis
- Figure 7. South America Neurotoxin Market: Impact Analysis of Drivers and Restraints
- Figure 8. South America Neurotoxin Market - Revenue Forecast and Analysis - 2021-2028
- Figure 9. South America Neurotoxin Market Revenue Share, by Type (2022 and 2028)
- Figure 10. Botox: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 11. Dysport: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 12. Xeomin: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 13. Others: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 14. South America Neurotoxin Market Revenue Share, by Application (2022 and 2028)
- Figure 15. Therapeutic: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 16. Aesthetic: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 17. South America Neurotoxin Market Revenue Share, by End User (2022 and 2028)
- Figure 18. Hospitals: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 19. Medical Spas and Beauty Centers: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 20. Dermatology Clinics: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 21. Others: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 22. South America: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
- Figure 23. South America: Neurotoxin Market, by Country, 2022 & 2028 (%)
- Figure 24. Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 25. Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 26. Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 27. Rest of South America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
The South America neurotoxins market is expected to grow from US$ 280.48 million in 2023 to US$ 525.57 million by 2028. It is estimated to register a CAGR of 13.4% from 2023 to 2028.
Emergence of Innovative Facial Aesthetic Products Fuels South America Neurotoxins Market
The overall market for neurotoxins is expected to propel exponentially during the forecast period to meet the growing demand for facial aesthetics. In March 2022, Aquavit Pharmaceuticals, Inc. announced the submission of an Investigational New Drug (IND) of "DTX-021"-a botulinum toxin type A intended to treat moderate to severe glabellar lines. The product is a highly purified and clinically tested injectable neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum. Also, Aquavit is accelerating clinical trials by introducing DTX-022, and its final approval will be recognized as the first-of-its-kind and the world's first pan-facial microinjection of neurotoxins. Likewise, with the ongoing weight loss trend, Gastric Botox has become a popular choice among patients seeking non-invasive procedures. It involves injecting Botox into specific stomach regions using an endoscopic technique. By this technique, the contraction of the stomach muscles is restrained. Due to the limitation, the stomach's evacuation process takes longer, which causes the patient to feel full for longer period, resulting in reduced appetite and improved weight-related health issues/lifestyle disorders such as high blood pressure and diabetes mellitus. Therefore, emergence of innovative facial aesthetic products helps the South America neurotoxin market to grow.
South America Neurotoxins Market Overview
The South America neurotoxin market is segmented into Brazil, Argentina, Venezuela, and the Rest of South America. Growth in this market is mainly driven by the growing adoption of minimally invasive and non-invasive aesthetic procedures, rising adoption among geriatric individuals, increasing public awareness about cosmetic procedures, availability of technologically advanced & user-friendly products, and increasing demand for aesthetic treatments. The regional market is likely to propel during the forecasted period owing to the recent technological developments that have made a direct impact on the economy of Brazil that has advanced to a large extent. In Brazil, the adoption of minimally invasive and non-invasive cosmetic procedures with a broad range of indications, such as botulinum-toxin-based treatment, are the major market drivers. The brand names of botulinum toxin A formulations available in Brazil involve Botox, Xeomin, Dysport, Botulift, and Prosigne. Additionally, the International Society of Aesthetics and Plastic Surgeons (ISAPS) 2018 report reveals that botulinum toxin-based treatment was the most common non-surgical procedure performed in Brazil, accounting for 51% (approx. 392,530) of the total non-surgical procedures. The cost savings advantage and higher work efficiencies achieved are cited as the major attracting points for manufacturing companies to establish bases in South America.
South America Neurotoxins Market Revenue and Forecast to 2028 (US$ Million)
South America Neurotoxins Market Segmentation
The South America neurotoxins market is segmented into product type, application, end user, and country.
Based on product type, the South America neurotoxins market is subsegmented into botox, dysport, xenomin, and others. The botox segment registered the largest market share in 2023.
Based on application, the South America neurotoxins market is segmented into therapeutic and aesthetic. The aesthetic segment held a larger market share in 2023.
Based on end user, the South America neurotoxins market is segmented into hospitals, specialty clinics, dermatology clinics, and others. The hospitals segment held the largest market share in 2023.
Based on country, the South America neurotoxins market is segmented into Brazil, Argentina, Venezuela, and the Rest of South America. Brazil dominated the market share in 2023.
AbbVie Inc, Hugel Inc, Ipsen SA, Medytox Inc, and Merz Pharma GmbH & Co KGaA are among the leading companies operating in the South America neurotoxins market.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America neurotoxins market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South America neurotoxins market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South America market trends and outlook coupled with the factors driving the neurotoxins market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 South America Neurotoxin Market - by Type
- 1.3.2 South America Neurotoxin Market - by Application
- 1.3.3 South America Neurotoxin Market - by End User
- 1.3.4 South America Neurotoxin Market - by Country
2. South America Neurotoxin Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. South America Neurotoxin Market - Market Landscape
- 4.1 Overview
- 4.2 South America PEST Analysis
- 4.3 Expert Opinion
5. South America Neurotoxin Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Surge in Cosmetic Procedures to Improve Appearance
- 5.1.2 Emergence of Innovative Facial Aesthetic Products
- 5.2 Market Restraints
- 5.2.1 Improper/Inappropriate Injection Technique
- 5.3 Future Trends
- 5.3.1 BOTA for Assisted Reproductive Technology (ART)
- 5.4 Impact Analysis
6. South America Neurotoxin Market
- 6.1 South America Neurotoxin Market Revenue Forecast and Analysis
7. South America Neurotoxin Market - Revenue and Forecast to 2028 - By Type
- 7.1 Overview
- 7.2 South America Neurotoxin Market Revenue Share, by Type (2022 and 2028)
- 7.3 Botox
- 7.3.1 Overview
- 7.3.2 Botox: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4 Dysport
- 7.4.1 Overview
- 7.4.2 Dysport: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5 Xeomin
- 7.5.1 Overview
- 7.5.2 Xeomin: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
8. South America Neurotoxin Market - Revenue and Forecast to 2028 - By Application
- 8.1 Overview
- 8.2 South America Neurotoxin Market Revenue Share, by Application (2022 and 2028)
- 8.3 Therapeutic
- 8.3.1 Overview
- 8.3.2 Therapeutic: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Aesthetic
- 8.4.1 Overview
- 8.4.2 Aesthetic: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9. South America Neurotoxin Market - Revenue and Forecast to 2028 - By End User
- 9.1 Overview
- 9.2 South America Neurotoxin Market Revenue Share, by End User (2022and 2028)
- 9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4 Medical Spas and Beauty Centers
- 9.4.1 Overview
- 9.4.2 Medical Spas and Beauty Centers: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5 Dermatology Clinics
- 9.5.1 Overview
- 9.5.2 Dermatology Clinics: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10. South America Neurotoxin Market -Revenue and Forecast to 2028- Country Analysis
- 10.1 Overview
- 10.1.1 South America: Neurotoxin Market, by Country, 2022 & 2028 (%)
- 10.1.1.1 Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 Overview
- 10.1.1.1.2 Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.3 Brazil: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
- 10.1.1.1.4 Brazil: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
- 10.1.1.1.5 Brazil: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
- 10.1.1.2 Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Overview
- 10.1.1.2.2 Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.3 Argentina: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
- 10.1.1.2.4 Argentina: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
- 10.1.1.2.5 Argentina: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
- 10.1.1.3 Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Overview
- 10.1.1.3.2 Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.3 Venezuela: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
- 10.1.1.3.4 Venezuela: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
- 10.1.1.3.5 Venezuela: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
- 10.1.1.4 Rest of South America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Overview
- 10.1.1.4.2 Rest of South America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.3 Rest of South America: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
- 10.1.1.4.4 Rest of South America: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
- 10.1.1.4.5 Rest of South America: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
- 10.1.1.1 Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1 South America: Neurotoxin Market, by Country, 2022 & 2028 (%)
11. South America Neurotoxins Market-Industry Landscape
- 11.1 Overview
- 11.2 Organic Growth Strategies
- 11.2.1 Overview
- 11.3 Inorganic Growth Strategies
- 11.3.1 Overview
12. Company Profiles
- 12.1 Merz Pharma GmbH & Co KGaA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 AbbVie Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Ipsen SA
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Medytox Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Hugel Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
